Constitutively Active Onco-GPCR in Uveal Melanoma Date & Time Friday, November 3rd / 4:20 PM About Victoria Rasmussen "Victoria Rasmussen is a graduate fellow in Dr. Victoria started her Ph.D. at the Tri-Institutional Ph.D. program in Chemical Biology, where she joined states to help test the feasibility of using protein-targeted degradation as a therapeutic strategy. " Victoria

Khaled Abdelrahman, Victoria Rasmussen and Madelyn Moore About Dr. Khaled Abdelrahman " Dr. GPCR About Victoria Rasmussen "Victoria Rasmussen is a graduate fellow in Dr. Victoria started her Ph.D. at the Tri-Institutional Ph.D. program in Chemical Biology, where she joined states to help test the feasibility of using protein-targeted degradation as a therapeutic strategy. " Victoria

Authors Victoria H Wu , Bryan S Yung , Farhoud Faraji , Robert Saddawi-Konefka , Zhiyong Wang , Alexander

Prasenjit Saha About Dr. Prasenjit Saha I conducted my doctoral research at the Indian Institute of Science, Bangalore, India, Prasenjit Saha on the web Google Scholar Pubmed LinkedIn Dr.

siRNA-mediated knockdown of YES1, and transfection of epitogue-tagged YAP mutants in PANC-1 and Mia PaCa potently and synergistically inhibited colony formation by PDAC cells and suppressed the growth of Mia PaCa

Proliferation Willem Berend Post Abstract Only available for AGPCR 24 Attendees Authors & Affiliations "Groß Victoria

PM Developing a PROTAC to Degrade the Constitutively Active Onco-GPCR in Uveal Melanoma Poster Talk Victoria